首页 | 本学科首页   官方微博 | 高级检索  
检索        


The Microbiome as a Therapy in Pouchitis and Ulcerative Colitis
Authors:Jean-Frdric LeBlanc  Jonathan P Segal  Lucia Maria de Campos Braz  Ailsa L Hart
Institution:1.Inflammatory Bowel Disease Unit, St. Mark’s Hospital, Harrow HA1 3UJ, UK; (L.M.d.C.B.); (A.L.H.);2.Department of Gastroenterology, The Hillingdon Hospital, Uxbridge UB8 3NN, UK;3.Faculty of Medicine, Department of Metabolism, Digestion and Reproduction, Imperial College, London SW7 2AZ, UK
Abstract:The gut microbiome has been implicated in a range of diseases and there is a rapidly growing understanding of this ecosystem’s importance in inflammatory bowel disease. We are yet to identify a single microbe that causes either ulcerative colitis (UC) or pouchitis, however, reduced microbiome diversity is increasingly recognised in active UC. Manipulating the gut microbiome through dietary interventions, prebiotic and probiotic compounds and faecal microbiota transplantation may expand the therapeutic landscape in UC. Specific diets, such as the Mediterranean diet or diet rich in omega-3 fatty acids, may reduce intestinal inflammation or potentially reduce the risk of incident UC. This review summarises our knowledge of gut microbiome therapies in UC and pouchitis.
Keywords:ulcerative colitis  ileoanal pouch inflammatory bowel disease  microbiota
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号